- Home
- COLL vs GATO Comparison
COLL vs GATO Comparison
Compare COLL & GATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- GATO
- Stock Information
- Founded
- COLL 2002
- GATO 2009
- Country
- COLL United States
- GATO Canada
- Employees
- COLL N/A
- GATO 882
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- GATO Precious Metals
- Sector
- COLL Health Care
- GATO Basic Materials
- Exchange
- COLL Nasdaq
- GATO Nasdaq
- Market Cap
- COLL 1.1B
- GATO 1.1B
- IPO Year
- COLL 2015
- GATO 2020
- Fundamental
- Price
- COLL $29.58
- GATO $15.92
- Analyst Decision
- COLL Strong Buy
- GATO Hold
- Analyst Count
- COLL 6
- GATO 3
- Target Price
- COLL $42.00
- GATO $13.25
- AVG Volume (30 Days)
- COLL 440.1K
- GATO 1.2M
- Earning Date
- COLL 11-07-2024
- GATO 11-11-2024
- Dividend Yield
- COLL N/A
- GATO N/A
- EPS Growth
- COLL 757.11
- GATO 513.84
- EPS
- COLL 2.16
- GATO 0.47
- Revenue
- COLL $599,245,000.00
- GATO N/A
- Revenue This Year
- COLL $13.02
- GATO N/A
- Revenue Next Year
- COLL $18.01
- GATO $2.69
- P/E Ratio
- COLL $13.68
- GATO $33.97
- Revenue Growth
- COLL 9.62
- GATO N/A
- 52 Week Low
- COLL $25.07
- GATO $5.42
- 52 Week High
- COLL $42.29
- GATO $20.31
- Technical
- Relative Strength Index (RSI)
- COLL 26.96
- GATO 42.90
- Support Level
- COLL $29.69
- GATO $15.27
- Resistance Level
- COLL $35.62
- GATO $17.29
- Average True Range (ATR)
- COLL 1.41
- GATO 0.86
- MACD
- COLL -0.39
- GATO -0.39
- Stochastic Oscillator
- COLL 6.36
- GATO 15.76
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About GATO Gatos Silver Inc.
Gatos Silver Inc is a development and exploration company. It is focused on the production of Cerro Los Gatos Mine and the further exploration and development of the Los Gatos District, both located in Chihuahua, Mexico. The Los Gatos District consists of 14 mineralized zones, including three identified silver-lead-zinc deposits: the Cerro Los Gatos Mine, the Esther deposit, and the Amapola deposit. The Company's reportable segments are based on the Company's mineral interests and management structure and include Mexico and Corporate segments. The Mexico segment engages in the exploration, development, and operation of the Company's Mexican mineral interests and includes the Company's investment in its LGJV.